Sörgel F[au] - Search Results

Year	Number of Results
1980	5
1982	2
1983	2
1984	3
1985	6
1986	3
1987	4
1988	7
1989	14
1990	3
1991	7
1992	10
1993	10
1994	6
1995	3
1996	5
1997	3
1998	9
1999	2
2000	2
2001	6
2002	3
2003	2
2004	7
2005	7
2006	6
2007	7
2008	10
2009	18
2010	12
2011	10
2012	4
2013	5
2014	6
2015	5
2016	5
2017	7
2018	7
2019	16
2020	6
2021	5
2022	2

1

Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Nau R, Sörgel F, Eiffert H. Nau R, et al. Among authors: sorgel f. Clin Microbiol Rev. 2010 Oct;23(4):858-83. doi: 10.1128/CMR.00007-10. Clin Microbiol Rev. 2010. PMID: 20930076 Free PMC article. Review.

2

Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.

Sörgel F, Malin JJ, Hagmann H, Kinzig M, Bilal M, Eichenauer DA, Scherf-Clavel O, Simonis A, El Tabei L, Fuhr U, Rybniker J. Sörgel F, et al. J Antimicrob Chemother. 2021 Feb 11;76(3):825-827. doi: 10.1093/jac/dkaa500. J Antimicrob Chemother. 2021. PMID: 33251541 Free PMC article. No abstract available.

3

Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sörgel F. Landersdorfer CB, et al. Among authors: sorgel f. Clin Pharmacokinet. 2009;48(2):89-124. doi: 10.2165/00003088-200948020-00002. Clin Pharmacokinet. 2009. PMID: 19271782 Review.

4

A systematic review of the stability of finished pharmaceutical products and drug substances beyond their labeled expiry dates.

Zilker M, Sörgel F, Holzgrabe U. Zilker M, et al. Among authors: sorgel f. J Pharm Biomed Anal. 2019 Mar 20;166:222-235. doi: 10.1016/j.jpba.2019.01.016. Epub 2019 Jan 11. J Pharm Biomed Anal. 2019. PMID: 30660807

5

Central nervous system infections and antimicrobial resistance: an evolving challenge.

Nau R, Sörgel F, Eiffert H. Nau R, et al. Among authors: sorgel f. Curr Opin Neurol. 2021 Jun 1;34(3):456-467. doi: 10.1097/WCO.0000000000000931. Curr Opin Neurol. 2021. PMID: 33767092 Review.

6

[Pharmacokinetics and pharmacodynamics of antibiotics in intensive care].

Sörgel F, Höhl R, Glaser R, Stelzer C, Munz M, Vormittag M, Kinzig M, Bulitta J, Landersdorfer C, Junger A, Christ M, Wilhelm M, Holzgrabe U. Sörgel F, et al. Med Klin Intensivmed Notfmed. 2017 Feb;112(1):11-23. doi: 10.1007/s00063-016-0185-5. Epub 2016 Oct 24. Med Klin Intensivmed Notfmed. 2017. PMID: 27778050 Review. German.

7

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.

Bulitta JB, Jiao Y, Drescher SK, Oliver A, Louie A, Moya B, Tao X, Wittau M, Tsuji BT, Zavascki AP, Shin BS, Drusano GL, Sörgel F, Landersdorfer CB. Bulitta JB, et al. Among authors: sorgel f. Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x. Clin Pharmacokinet. 2019. PMID: 29936678 Review.

8

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients.

Lahmer T, Batres Baires G, Schmid RM, Wiessner JR, Ulrich J, Reichert M, Huber W, Sörgel F, Kinzig M, Rasch S, Mayr U. Lahmer T, et al. Among authors: sorgel f. J Fungi (Basel). 2021 May 11;7(5):376. doi: 10.3390/jof7050376. J Fungi (Basel). 2021. PMID: 34064945 Free PMC article.

9

Metabolism of gyrase inhibitors.

Sörgel F. Sörgel F. Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1119-29. doi: 10.1093/clinids/11.supplement_5.s1119. Rev Infect Dis. 1989. PMID: 2549606 Review.

10

Pharmacokinetic characteristics of piperacillin/tazobactam.

Sörgel F, Kinzig M. Sörgel F, et al. Intensive Care Med. 1994 Jul;20 Suppl 3:S14-20. doi: 10.1007/BF01745246. Intensive Care Med. 1994. PMID: 7962984 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results